Five diabetes drugs for weight and fat reduction, suitable for obese type 2 diabetes.

· Metformin improves insulin resistance, interferes with fat metabolism, reduces appetite, and can lead to a weight loss of 5~10% after medication.

· Acarbose slows down the absorption of carbohydrates in the intestine, reducing calorie intake, and can control post-meal blood sugar levels after medication, also leading to weight loss.

· Gliclazide improves insulin sensitivity, lowers blood sugar, and can also reduce the accumulation of visceral fat, showing particularly significant effects in weight loss for friends with type 2 diabetes.

· Dapagliflozin controls the reabsorption of glucose by the renal tubules, excreting excess sugar and reducing its conversion to fat, which is beneficial for weight control. Additionally, when renal tubules excrete glucose, they carry away a significant amount of water, also contributing to weight loss.

·GLP-1 receptor agonists semaglutide and liraglutide inhibit the secretion of digestive fluids and intestinal motility, delay gastric emptying, and can also act on the central nervous system to produce a feeling of fullness, making them suitable for friends with type 2 diabetes who are obese.

Therefore, it is not surprising to find weight loss when taking the above five types of hypoglycemic drugs. It must be emphasized that the purpose of using these drugs is to control blood sugar, and some beauty-conscious women should not use them as weight-loss medications on their own, as this often leads to adverse consequences. Additionally, diabetic friends who are already underweight should consult a specialist doctor to choose other hypoglycemic medications.